CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 3, 2013--
Verastem, Inc., (NASDAQ: VSTM) a clinical-stage biopharmaceutical
company focused on discovering and developing drugs to treat cancer by
the targeted killing of cancer stem cells, announced that members of the
management team will be presenting at several upcoming conferences. The
presentation details are as follows:
-
East/West CEO Conference on Sunday, January 6, 2013, at the Four
Seasons Hotel in San Francisco, CA
-
31st Annual J.P. Morgan Healthcare Conference on Thursday,
January 10, 2013, at 11:30 am PT at the Westin St. Francis Hotel in
San Francisco, CA. Following the presentation there will be a breakout
session from 12:00-12:30 pm PT in the Sussex Room 30. A webcast of the
presentation can be accessed by visiting the investors section of the
Company’s website at www.verastem.com.
A replay of the webcast will be archived on the Verastem website for
two weeks following the presentation date.
About Verastem, Inc.
Verastem, Inc. (NASDAQ: VSTM) is a clinical-stage biopharmaceutical
company focused on discovering and developing drugs to treat cancer by
the targeted killing of cancer stem cells. Cancer stem cells are an
underlying cause of tumor recurrence and metastasis. Verastem is
developing small molecule inhibitors of signaling pathways that are
critical to cancer stem cell survival and proliferation: FAK, PI3K/mTOR
and Wnt. For more information, please visit www.verastem.com.
Forward-looking statements:
Any statements in this press release about future expectations, plans
and prospects for the Company constitute forward-looking statements.
Actual results may differ materially from those indicated by such
forward-looking statements. The Company anticipates that subsequent
events and developments will cause the Company’s views to change.
However, while the Company may elect to update these forward-looking
statements at some point in the future, the Company specifically
disclaims any obligation to do so.
Source: Verastem, Inc.
Verastem, Inc.
Investor contact:
Brian Sullivan,
617-252-9314
bsullivan@verastem.com
or
Media
contact:
Kari Watson, 781-235-3060
kwatson@macbiocom.com
View printer-friendly version
